Vanda Pharmaceuticals, Inc. (VNDA)

7.26 -0.07 (-0.95%) USD  |  NASDAQ  |  Jan 12, 12:17
More

Vanda Pharmaceuticals Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for VNDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Aldeyra Therapeutics, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Eli Lilly & Co. Upgrade
Exelixis, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade